29.61
0.24%
0.07
시간 외 거래:
29.40
-0.21
-0.71%
Tg Therapeutics Inc (TGTX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
44.35%
63.47
|
43.97 | 165.81 | 16.07 | 7.803 |
Cost Of Revenue |
30.72%
5.441
|
7.854 | 3.509 | - | - |
Gross Profit |
60.68%
58.03
|
36.12 | 162.31 | - | - |
Operating Expenses
|
38.48%
67.30
|
48.60 | 47.52 | 60.75 | 44.80 |
Interest Income/Expense |
5.88%
2.288
|
2.431 | 3.713 | 3.627 | 2.844 |
Benefits Costs and Expenses |
15.81%
74.15
|
64.03 | 51.03 | 63.68 | 47.03 |
Costs And Expenses |
28.85%
72.74
|
56.46 | 51.03 | 63.68 | 47.03 |
Operating Income/Loss |
25.75%
-9.27
|
-12.48 | 114.78 | -44.67 | -36.99 |
Nonoperating Income/Loss |
8.63%
-1.408
|
-1.541 | -0.854 | -2.936 | -2.24 |
Income/Loss From Continuing Operations Before Tax |
46.76%
-10.68
|
-20.06 | 114.78 | -47.61 | -39.23 |
Income Tax Expense/Benefit |
0.029
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
25.73%
-10.71
|
-14.42 | 113.93 | -47.61 | -39.23 |
Net Income/Loss
|
25.73%
-10.71
|
-14.42 | 113.93 | -47.61 | -39.23 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
38,042%
146.21
|
0.3833 | 142.87 | 141.50 | 140.31 |
Basic Earnings Per Share |
30.00%
-0.07
|
-0.10 | 0.80 | -0.34 | -0.28 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):